Further development of multi-antigen vaccines for primary and secondary prevention of bladder cancer HHSN2612015000361 to: HHSN26100011 PP: 9/17/2018 to 3/16/2020
Ended Awarded Last action
- Contract number
- 75N91018F00011
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $901,729
Award facts
- Opportunity
-
- N01CN201500036 Solicitation number
- Contract value 100% obligated
- $901,729.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $231,523 | |
| Original award | $670,206 |
About this award
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the University of Alabama at Birmingham (UAB) for the further development of multi-antigen vaccines for the primary and secondary prevention of bladder cancer. The contract has a firm fixed price of $901,729.00 and a period of performance from September 17, 2018 to March 16, 2020, with a final completion date of December 16, 2022.
The contract is part of the National Cancer Institute's Preclinical Prevent Cancer Program, which focuses on preclinical efficacy and intermediate endpoint biomarkers. UAB is the prime contractor, and the University of Washington is a subcontractor on the project. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N91018F00011?
75N91018F00011 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 17, 2018.
How much is contract 75N91018F00011 worth?
The government has obligated $901,729 on 75N91018F00011.
Is contract 75N91018F00011 an order under another contract?
Yes. 75N91018F00011 is a delivery order under HHSN261201500036I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract 75N91018F00011 competed?
The extent of competition for 75N91018F00011 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award